36117625|t|The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.
36117625|a|Currently, there is no disease-modifying treatment available for Alzheimer's and Parkinson's disease (AD and PD) and that includes the highly controversial approval of the Abeta-targeting antibody aducanumab for the treatment of AD. Hence, there is still an unmet need for a neuroprotective drug treatment in both AD and PD. Type 2 diabetes is a risk factor for both AD and PD. Glucagon-like peptide 1 (GLP-1) is a peptide hormone and growth factor that has shown neuroprotective effects in preclinical studies, and the success of GLP-1 mimetics in phase II clinical trials in AD and PD has raised new hope. GLP-1 mimetics are currently on the market as treatments for type 2 diabetes. GLP-1 analogs are safe, well tolerated, resistant to desensitization and well characterized in the clinic. Herein, we review the existing evidence and illustrate the neuroprotective pathways that are induced following GLP-1R activation in neurons, microglia and astrocytes. The latter include synaptic protection, improvements in cognition, learning and motor function, amyloid pathology-ameliorating properties (Abeta, Tau, and alpha-synuclein), the suppression of Ca2+ deregulation and ER stress, potent anti-inflammatory effects, the blockage of oxidative stress, mitochondrial dysfunction and apoptosis pathways, enhancements in the neuronal insulin sensitivity and energy metabolism, functional improvements in autophagy and mitophagy, elevated BDNF and glial cell line-derived neurotrophic factor (GDNF) synthesis as well as neurogenesis. The many beneficial features of GLP-1R and GLP-1/GIPR dual agonists encourage the development of novel drug treatments for AD and PD.
36117625	31	54	glucagon-like peptide 1	Gene	2641
36117625	58	93	Alzheimer's and Parkinson's disease	Disease	MESH:D010300
36117625	180	215	Alzheimer's and Parkinson's disease	Disease	MESH:D010300
36117625	217	219	AD	Disease	MESH:D000544
36117625	224	226	PD	Disease	MESH:D010300
36117625	287	292	Abeta	Gene	351
36117625	312	322	aducanumab	Chemical	MESH:C000600266
36117625	344	346	AD	Disease	MESH:D000544
36117625	429	431	AD	Disease	MESH:D000544
36117625	436	438	PD	Disease	MESH:D010300
36117625	440	455	Type 2 diabetes	Disease	MESH:D003924
36117625	482	484	AD	Disease	MESH:D000544
36117625	489	491	PD	Disease	MESH:D010300
36117625	493	516	Glucagon-like peptide 1	Gene	2641
36117625	518	523	GLP-1	Gene	2641
36117625	646	651	GLP-1	Gene	2641
36117625	692	694	AD	Disease	MESH:D000544
36117625	699	701	PD	Disease	MESH:D010300
36117625	723	728	GLP-1	Gene	2641
36117625	784	799	type 2 diabetes	Disease	MESH:D003924
36117625	801	806	GLP-1	Gene	2641
36117625	1019	1025	GLP-1R	Gene	2740
36117625	1171	1178	amyloid	Disease	MESH:C000718787
36117625	1214	1219	Abeta	Gene	351
36117625	1221	1224	Tau	Gene	4137
36117625	1230	1245	alpha-synuclein	Gene	6622
36117625	1267	1271	Ca2+	Chemical	-
36117625	1312	1324	inflammatory	Disease	MESH:D007249
36117625	1368	1393	mitochondrial dysfunction	Disease	MESH:D028361
36117625	1447	1454	insulin	Gene	3630
36117625	1551	1555	BDNF	Gene	627
36117625	1560	1603	glial cell line-derived neurotrophic factor	Gene	2668
36117625	1605	1609	GDNF	Gene	2668
36117625	1678	1684	GLP-1R	Gene	2740
36117625	1689	1694	GLP-1	Gene	2641
36117625	1695	1699	GIPR	Gene	2696
36117625	1769	1771	AD	Disease	MESH:D000544
36117625	1776	1778	PD	Disease	MESH:D010300
36117625	Positive_Correlation	2740	627
36117625	Association	MESH:D010300	2641
36117625	Association	MESH:D010300	2696
36117625	Association	MESH:C000600266	351
36117625	Association	MESH:D007249	2740
36117625	Association	MESH:D010300	2740
36117625	Negative_Correlation	MESH:C000600266	MESH:D000544
36117625	Association	MESH:C000718787	4137
36117625	Association	MESH:D000544	351
36117625	Bind	2641	2696
36117625	Association	MESH:D000544	2641
36117625	Association	MESH:C000718787	6622
36117625	Association	MESH:D000544	2696
36117625	Positive_Correlation	2668	2740
36117625	Association	MESH:D028361	2740
36117625	Positive_Correlation	2740	6622
36117625	Association	MESH:D000544	2740

